Save the Date: 11 – 13 June 2026 in Ljubljana
Paediatric Working Group is launching the first survey!
Dear colleagues,
Paediatric Working Group of ESOP is launching the first survey about the role of the pharmacist in paediatric oncology.
We are aiming to collect the view and the practises from all over the world to compare, analyse and understand, what could be the harmonisation options between us and how could the special education look like.
We NEED YOU to forward this survey to all your colleagues working in the paediatric oncology, we need each answer of every team member with pharmaceutical degree from paediatric field! It is not obligatory to work only in paediatrics.
The survey will take about 15 minutes to complete; it contains open questions and multiple-choice questions. This input will be used to formulate key recommendations that will inform the portfolio of the paediatric oncology pharmacist worldwide.
Thank you in advance.
Ar cieņu,
Svetlana Buraja
Manifesto for Collaboration in Oncology Pharmacy
We, the global community of oncology pharmacists, recognize that the challenges we face are universal – and can only be overcome together.
Although ESOP, our society, already reaches 99 countries worldwide, there is still so much to be done. Cancer knows no borders, and neither should our commitment.
We call upon all colleagues to work together for a better future in oncology pharmacy.
Only by standing united can we make the difference – today, tomorrow, and for generations to come.
Yours Klaus Meier
A Heartfelt Thank you for Supporting the "Yellow Hand" Initiative
The European Society of Oncology Pharmacy (ESOP) extends its sincere gratitude to all pharmaceutical companies and healthcare professionals who have embraced the “Yellow Hand”
symbol as a mark of safety, responsibility, and care. We sincerely hope to continue encouraging everyone involved in the handling and transport of cytotoxic drugs to actively support and promote the use of the “Yellow Hand” as a symbol of safety and care.
For over a decade, their shared commitment has played a vital role in protecting healthcare workers and patients alike by ensuring the safe handling and transport of cytotoxic drugs. By clearly identifying hazardous substances during both external shipping and internal delivery, they enable swift, professional responses in case of contamination and set a strong example for safety, sustainability, and best practices in healthcare logistics.
Clicking on the logo will lead you to further information about the initiative and its commitment to enhancing safety in the handling of cytotoxic drugs.
By decision of the General Assembly of 24th October 2018 in Nantes, the implementation of an organized membership survey in all member countries should be conducted.
In this survey, the possible goals and obstacles in the context of future development within the societies and thus also the Oncology Pharmacy should be surveyed and compiled at the end of the year in an overall report. A report about the results was published in EJOP (EJOP. 6(1):e00043, January-March 2023.)
ESOP is asking again. We encourage everyone to fill out this questionnaire again, because we want to know whether COVID and other crises have changed the goals and ideas about the future of oncology pharmacy.
ESOP supports the worldwide Petition
ESOP – the world’s largest multinational oncology pharmacy society,
supporting the interests of cancer patients.
Become a member
